the nature , objectives , and advantages of the invention will become more apparent to those skilled in the art after considering the following detailed description in connection with the accompanying drawings . one aspect of the invention concerns a machine - driven system to treat or prevent fever in hospital patients by administering medication , coolant , or other antipyretic means . this system may be implemented in various ways , one example being shown by the hardware components and interconnections shown by the system 100 of fig1 . the system 100 includes a controller 104 , one or more fever characteristic sensors 106 , a flow device 110 , a treatment substance administration path 108 , and a source 112 . the system 100 is utilized to automatically treat or even prevent fever in the patient 102 . as mentioned above , the system 100 includes one or more fever characteristic sensor ( s ) 106 . as used herein , “ fever ” is defined as bodily temperature that is above normal due to pathogens or other stimuli . the system of this invention may be configured to detect fever ; more advantageously from the standpoint of preventing fever , the invention may be configured to predictively detect the future onset of fever . utilizing the foregoing definition of fever , the presence of fever is easily determined by detecting an elevated body temperature . in this respect , the fever characteristic sensors 106 may include one or more temperature sensors , deployed in various regions of the body that accurately represent the temperature of the entire body , the body core , or a particular region . as an example , a single temperature sensor may be deployed at the esophagus , bladder , tympanic membrane , rectum , or another local site that is representative of the body &# 39 ; s core temperature . with multiple temperature sensors , the sensors may be distributed at various sites , and the resulting measurements averaged to provide a more accurate representation of the patient &# 39 ; s temperature . advantageously , the fever characteristic sensors 106 may also include other sensors to detect the onset of fever . since fever is preceded by increased metabolic rate , the sensors 106 may also include devices to detect increased oxygen consumption , increased carbon dioxide in exhaled air , decreased venous hemoglobin oxygen saturation , and the like . in the case of oxygen consumption or carbon dioxide measurement , the sensors 106 may comprise a gas analyzer coupled to automatic ventilation equipment or an open mask apparatus . in the case of venous hemoglobin oxygen measurement , relevant sensors 106 may comprise optical light reflectance and / or transmission devices , such as commercially available devices for detecting blood saturation . the treatment substance administration path 108 (“ path ”) provides a means to administer a treatment substance to the patient . the path 108 may be open - end or closed - end . with an open - end path , the treatment substance takes a one - way trip into a region of the patient &# 39 ; s body that is likely to absorb , distribute , or effectively process the treatment substance . the open - end treatment substance administration path , for example , may be routed to the patient &# 39 ; s stomach , veins , arteries , esophagus , or rectum . the open - end path is advantageous for treatment substances that comprise medication , such as acetaminophen , in which case an exemplary treatment substance administration path may comprise a device such as nasogastric tube . fig1 c shows an exemplary open - end path 140 . the path 140 comprises a conduit having a body 146 with an inlet 142 and an outlet 144 . the open - end treatment substance administration path 140 is deployed by inserting the outlet 144 into an artery , vein , stomach , rectum , skin , lungs or other suitable body access point . other examples of open - end path include a nasogastric tube , open - end catheter , intravenous needle , syringe , suppository , perforated tube for “ drip ” irrigation , transdermal patch , aerosol or other inhalant , etc . in contrast to the open - end path , treatment substance circulates within the closed - end path without actually contacting the patient &# 39 ; s body . this is beneficial if the treatment substance comprises a coolant such as saline . fig1 b shows an exemplary closed - end path 120 , which is embodied by a cooling catheter . the catheter 120 includes a housing 122 having distal 128 and proximal 130 ends . the housing 122 contains a conduit 123 that runs from the catheter &# 39 ; s proximal end 130 to the distal end 128 and back again . the conduit 123 has a supply opening 126 and a return opening 124 . the conduit 123 therefore provides a round - trip path internal to the catheter 120 , where this path is sealed from any contact with the patient &# 39 ; s body . the closed - end path 120 is deployed by inserting the distal end 128 into a suitable blood vessel such as the inferior vena cava . a number of exemplary catheters and their use are described in u . s . application ser . no . 09 / 321 , 515 , which was filed on may 27 , 1999 and is hereby incorporated by reference into the present application . the flow device 110 controls flow of the treatment substance from a source 112 to the patient to help prevent or abate the patient &# 39 ; s fever . in one embodiment , the flow device 110 may comprise a pump or other structure that actively causes the treatment substance to flow through the path from the source 112 , where the source comprises an intravenous bag , vial , jar , carton , box , or other storage facility . in another embodiment , the treatment substance flows by gravity and the flow device 110 comprises a valve , on - off switch , or other mechanism to regulate treatment substance flowing from the source 112 . here , the source 112 may comprise any intravenous bag , vial , jar , carton , box , or other storage facility , whether compressible or not . in still another embodiment , the source 112 has a dynamic volume and the treatment substance flows by reduction of the source &# 39 ; s volume . namely , the source 112 may be a self - compressed vessel ( e . g ., distended elastic container ), or a compressible vessel whose volume decreases under external force ( e . g ., syringe , hydraulic vessel , compressible intravenous bag , chamber with piston - driven lid , etc .). in the case of a self - compressed source 112 , the flow device 110 comprises a solenoid or other suitable device to regulate the amount of flow through the path ; in the case of an externally compressed source 112 , the flow device 110 comprises a compression mechanism such as a hydraulic pump , motor , piston , pinchers , screw - driven vise , etc . ordinarily skilled artisans ( having the benefit of this disclosure ) will recognize a variety of other options to implement the flow device 110 and source 112 . in the case of an open - end path , the flow device 110 regulates flow of the treatment substance directly into the patient &# 39 ; s body . in the case of a closed - end path , the flow device 110 regulates flow of the treatment substance into the supply opening ( e . g ., 126 , fig1 b ), and also collects spent treatment substance from the catheter &# 39 ; s return opening ( e . g ., 124 , fig1 b ). the flow device 110 deposits returned treatment substance into the return vessel 114 . the return vessel 114 may be omitted when an open - end path is used , or if the return vessel 114 leads to , or is combined with , the source 112 . when a closed - end path is used , equipment for cooling the treatment substance may be implemented at the source 112 , the flow device 110 , return vessel 114 , or other suitable location . if desired , the path 108 may be configured to incorporate one or more fever characteristic sensors 106 . for instance , a rectal temperature probe may be combined with a path designed for exposure or insertion of an antipyretic drug or suppository . in addition to the foregoing components , the controller 104 may be coupled to one or more additional controller - activated antipyretic apparatuses , whether related to the administration of treatment substance or not . some examples include inflatable cooling blankets , oscillating or fixed fans , air conditioning thermostats for room air or bath water , etc . the controller 104 receives measurements from the sensor ( s ) 106 , and serves to regulate operation of the flow device 110 according to predetermined specifications . to implement this automatic control feature , the controller 104 comprises an electronic module such as logic circuitry , discrete circuit elements , or a digital data processing apparatus ( computer ) that executes a program of machine - readable instructions . when implemented in logic circuitry or a computer , the controller 104 analyzes the patient &# 39 ; s temperature and / or other fever characteristic signals utilizing the controller &# 39 ; s own programming , and provides the resultant output signal to regulate the flow device 110 . when implemented in discrete circuitry , the circuitry or the controller 104 processes the patient &# 39 ; s fever characteristics with circuitry to provide a resultant output signal that regulates the flow device 110 . as mentioned above , one embodiment of the controller 104 is a digital data processing apparatus . this apparatus may be embodied by various hardware components and interconnections , one example appearing in fig2 . the apparatus 200 includes a processor 202 , such as a microprocessor or other processing machine , coupled to a storage 204 . in the present example , the storage 204 includes a fast - access storage 206 , as well as nonvolatile storage 208 . the fast - access storage 206 may comprise random access memory ( ram ), and may be used to store the programming instructions executed by the processor 202 . the nonvolatile storage 208 may comprise , for example , one or more magnetic data storage disks such as a “ hard drive ”, a tape drive , or any other suitable storage device . the apparatus 200 also includes an input / output 210 , such as a line , bus , cable , electromagnetic link , or other means for the processor 202 to exchange data with other hardware external to the apparatus 200 . despite the specific foregoing description , ordinarily skilled artisans ( having the benefit of this disclosure ) will recognize that the apparatus discussed above maybe implemented in a machine of different construction , without departing from the scope of the invention . as a specific example , one of the components 206 , 208 may be eliminated ; furthermore , the storage 204 may be provided on - board the processor 202 , or even provided externally to the apparatus 200 . in contrast to the digital data storage apparatus discussed previously , a different embodiment of the invention implements the controller 104 with logic circuitry instead of computer - executed instructions . depending upon the particular requirements of the application in the areas of speed , expense , tooling costs , and the like , this logic may be implemented by constructing an application - specific integrated circuit ( asic ) having thousands of tiny integrated transistors . such an asic may be implemented using cmos , ttl , vlsi , or another suitable construction . other alternatives include a digital signal processing chip ( dsp ), discrete circuitry ( such as resistors , capacitors , diodes , inductors , and transistors ), field programmable gate array ( fpga ), programmable logic array ( pla ), and the like . in addition to the structure described above , a different aspect of the invention concerns a process for automated fever abatement . as illustrated below , this process includes steps that are manually performed , such as preparing the patient for treatment . the process also includes automatic , machine - activated steps that treat or even prevent the patient &# 39 ; s fever . in the context of fig1 - 2 , the automated fever abatement process may be implemented , for example , by operating the controller 104 , as embodied by a digital data processing apparatus 200 , to execute a sequence of machine - readable instructions . these instructions may reside in various types of signal - bearing media . in this respect , one aspect of the present invention concerns a programmed product , comprising signal - bearing media tangibly embodying a program of machine - readable instructions executable by a digital data processor to operate the system 100 to perform automated fever abatement . this signal - bearing media may comprise , for example , ram ( not shown ) contained within the controller 104 , as represented by the fast - access storage 206 , for example . alternatively , the instructions may be contained in another signal - bearing media , such as a magnetic data storage diskette 300 ( fig3 ), directly or indirectly accessible by the processor 202 . whether contained in the diskette 300 , storage 204 , or elsewhere , the instructions may be stored on a variety of machine - readable data storage media , such as direct access storage ( e . g ., a conventional “ hard drive ,” redundant array of inexpensive disks ( raid ), or another direct access storage device ( dasd )), magnetic tape , electronic read - only memory ( e . g ., rom , eprom , or eeprom ), optical storage ( e . g ., cd - rom , worm , dvd , digital optical tape ), paper “ punch ” cards , or other suitable signal - bearing media including transmission media such as digital and analog and communication links and wireless . in an illustrative embodiment of the invention , the machine - readable instructions may comprise software object code , compiled from a language such as “ c ,” etc . in contrast to the signal - bearing medium discussed above , the method of automated fever abatement may be implemented using logic circuitry , without using a processor to execute instructions . in this embodiment , the logic circuitry is implemented in the controller 104 , and serves to perform an operational sequence according to this invention as described below . the logic circuitry may be implemented using many different types of circuitry , as discussed above . [ 0051 ] fig4 shows a sequence 400 that illustrates one example of the method aspect of the present invention . for ease of explanation , but without any intended limitation , the example of fig4 is described in the context of fig1 - 2 , as described above . after the sequence 400 is initiated in step 402 , medical staff prepare the patient for treatment ( step 404 ). as an example , such preparation may involve bathing , shaving , dressing , and other activities . next , medical staff interconnect the components of the system 100 and deploy the path 108 to the appropriate bodily site ( s ) ( step 406 ). alternatively , if the system 100 components are pre - assembled , the assembly steps are omitted . after step 406 , medical staff deploy the fever characteristic sensor ( s ) 106 at target regions of the patient &# 39 ; s body . upon completion of step 406 , the sensors begin to measure the relevant physiological characteristics and provide representative machine - readable outputs . as illustrated , steps 404 , 406 , and 408 are performed manually . as described below , however , steps 409 , 410 , 412 , and 414 are performed by the controller 104 and serve to implement an automated method of fever abatement . in step 409 , the controller 104 collects input for use in deciding how to operate the flow device 110 and thereby regulate the patient &# 39 ; s temperature . among other possible input , the input of step 409 includes input from the sensor ( s ) 106 , such as body temperature , metabolic rate , and other bodily characteristics affected by fever . the input may also include other information such as ( 1 ) whether the path 108 is closed - end or open - end , ( 2 ) if the path 108 is open - end , the strength of the medication that constitutes the treatment substance , ( 3 ) the volume output of the flow device 110 , ( 4 ) the patient &# 39 ; s temperature history , ( 5 ) the history of treatment substance application with the current patient , ( 6 ) any post - delivery time delay required for treatment substance to take effect , and ( 7 ) other such factors . after step 409 , the controller computes a supply strategy in step 410 . the supply strategy specifies a volume , timing , and rate of treatment substance supply that is calculated to regulate the patient &# 39 ; s temperature according to predetermined specifications . these predetermined specifications are pre - programmed into the controller 104 . as an example , the predetermined specifications may dictate keeping the patient &# 39 ; s core temperature at or below 37 . 5 degrees celsius , limiting any temperature excursions to a maximum time or temperature , etc . thus , the supply strategy constitutes the manner of treatment substance delivery that will achieve the predetermined specifications . to compute the supply strategy , the controller 104 considers the input from step 409 and applies a predetermined analysis to this data . the predetermined analysis may be specified by one or more equations , lookup tables , or other machine - readable information available to the controller 104 by software programming , hardware configuration , etc . to illustrate step 410 in greater detail some examples are provided . in a first example , the path 108 is closed - end and the treatment substance comprise room temperature or cooled saline , and the predetermined specifications require keeping the patient &# 39 ; s core temperature below 37 . 5 degrees celsius . here , one example of the controller &# 39 ; s strategy is ( 1 ) operating the flow device 110 to circulate coolant if the patient &# 39 ; s temperature reaches 37 . 5 degrees celsius , and ( 2 ) ceasing operation of the flow device 110 whenever the patient &# 39 ; s temperature is below 37 . 5 degrees celsius . in a second example , the path 108 is open - end and the treatment substance comprises one or more antipyretic drugs such as acetaminophen , aspirin , naproxen , ibuprofen , etc . in this example , the controller 104 may compute a strategy that activates the flow device 110 to administer a bolus of the treatment substance upon detecting fever or febral onset . bolus may be especially desirable because fever tends to occur in spikes with rapid onset , and rapid initial delivery in a bolus may rapidly establish a meaningful blood concentration of the antipyretic treatment substance . as an alternative strategy , an initial bolus of one drug may be administered , and if fever persists , a second larger bolus of the same drug or a bolus of a second antipyretic drug is administered . furthermore , once fever is detected ( or febral inset predicted ), the treatment substance may be administered with an increasing rate if a preset body temperature is reached or if a predetermined rate of temperature increase is detected . after the supply strategy is computed in step 410 , the controller 104 directs the administration equipment 100 to implement this strategy in step 412 . namely , the controller 104 directs the flow device 110 to begin delivering the treatment substance to the path 108 according to the computed supply strategy . where the flow device 110 comprises a valve , step 412 involves opening , closing , or adjusting constriction of the valve . where the flow device 110 is a pump , the flow rate may be controlled by varying pump speed or repeatedly turning a constant - speed pump on and off . also in step 412 , the controller 104 may record the time that treatment began for subsequent documentation by nurses , etc . in step 414 , the controller 104 determines whether it has received an “ off ” command . the “ off ” command may be received by keyboard entry , manual activation of a switch ( not shown ) coupled to the controller 104 , expiration of a pre - programmed treatment period , etc . if the “ off ” command has not been received , the sequence 400 returns to step 409 , whereupon the controller 104 receives further input from the sensors 106 , adjusts the supply strategy if necessary ( step 410 ), and directs the components of the system 100 accordingly ( step 412 ). when step 414 receives the “ off ” command , the routine 400 ends in step 416 . while the foregoing disclosure shows a number of illustrative embodiments of the invention , it will be apparent to those skilled in the art that various changes and modifications can be made herein without departing from the scope of the invention as defined by the appended claims . furthermore , although elements of the invention may be described or claimed in the singular , the plural is contemplated unless limitation to the singular is explicitly stated .
a method for treating fever by establishing a closed loop pathway to flow a treatment substance through a patient &# 39 ; s body without the substance entering the patient &# 39 ; s bloodstream , by engaging a fever characteristic sensor with the patient , by receiving a signal from such sensor and using the controller to control temperature and / or flow of the treatment substance .